<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158179">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02037893</url>
  </required_header>
  <id_info>
    <org_study_id>PNX-CL-001</org_study_id>
    <nct_id>NCT02037893</nct_id>
  </id_info>
  <brief_title>Four Arm Safety &amp; Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media</brief_title>
  <official_title>A Four-arm, Randomized, Double-blind, Active and Placebo Controlled Study to Determine the Safety and Efficacy of a Combination Antupyrine and Benzocaine Otic Solution Compared With Antipyrine Otic Solution Alone, Benzocaine Otic Solution Alone and to Placebo Otic Solution to Relieve Pain Symptoms in Children With Acute Otitis Media.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pernix Theraputics LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pernix Theraputics LLC</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to compare the effect of treatment with a combination of ear
      solutions on the reduction of pain symptoms at 1 hour after dosing in children with acute
      otitis media.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reduction of pain symptoms will be measured by using the Face, Legs, Activity, Cry,
      Consolability Scale (FLACC) and the Faces pain Scale Revised (FPS-R).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Face, Legs, Activity, Cry, Consolibility Scale (FLACC) or Faces Pain Scale Revised (FPS-R)</measure>
    <time_frame>1 hour after  a single dose</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction of pain symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FLACC or FPS-R</measure>
    <time_frame>Dosing every 3 hours for 1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Effect of dosing every 3 hours for 1 day in the reduction of pain symptoms over 3 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FLACC or FPS-R</measure>
    <time_frame>Effect of dosing every 3 hours for 1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>The effect of dosing every 3 hours for  1 day on percent of subjects with complete or partial pain relief</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety as assessed by Adverse Events</measure>
    <time_frame>3 days after 1 day of treatment</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>AEs to be assessed for  a period of 3 days after 1 day of dosing.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Acute Otitis Media</condition>
  <arm_group>
    <arm_group_label>Antipyrine and Benzocaine Otic solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>antipyrine 54 mg and benzocaine 14 mg. Apply drops along the wall of the ear canal until filled and repeating every 3 hours for 24 hours unless the subject is sleeping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antipyrine Otic Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antipyrine 54 mg and glycerine dehydrated to 1.0 mL. Apply drops along the wall of the ear canal until filled and repeating every 3 hours for 24 hours unless the subject is sleeping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Benzocaine Otic Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>benzocaine 14 mg and glycerine dehydrated to 1.0 ml. Apply drops along the wall of the ear canal until filled and repeating every 3 hours for 24 hours unless the subject is sleeping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo otic solution will be glycerin that is dehydrated .  Apply drops along the wall of the ear canal until filled and repeating every 3 hours for 24 hours unless the subject is sleeping</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antipyrine and Benzocaine otic solution</intervention_name>
    <arm_group_label>Antipyrine and Benzocaine Otic solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antipyrine Otic Solution</intervention_name>
    <arm_group_label>Antipyrine Otic Solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzocaine Otic Solution</intervention_name>
    <arm_group_label>Benzocaine Otic Solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Otic solution</intervention_name>
    <arm_group_label>Antipyrine and Benzocaine Otic solution</arm_group_label>
    <arm_group_label>Antipyrine Otic Solution</arm_group_label>
    <arm_group_label>Benzocaine Otic Solution</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical Diagnosis of Acute Otitis Media

          -  Moderate to severe pain

          -  Normally active and in good health as determined by the PI

          -  Parent or legal guardian consent

          -  Caregiver available to complete diaries during study

        Exclusion Criteria:

          -  History of or current Perforated tympanic membrane

          -  Tympanostomy tubes

          -  Acute or chronic otitis externa

          -  seborrheic dermatitis

          -  Received any otic topical or systemic antibiotic within 14 days of enrollment

          -  Receiving medication on a chronic basis for pain

          -  Known hypersensitivity to investigational product.

          -  clinical significant mental illness as determined by the PI

          -  Exposed to another investigational agent within 30 days before study entry. Any
             condition the PI believed will interfere with the ability to comply with all study
             procedures

          -  History of glucose 6-phosphate dehydrogenase deficiency

          -  History or currently anemic

          -  Congenital methemoglobinemia

          -  Recent history of acute gastroenteritis within 14 days of enrollment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Goldberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Visions Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerald Shockey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Desert Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shane Christensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foothill Family Clinic South</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephanie Plunkett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Med East</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katie Julien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jordan River Family Medcine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Peterson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foothill Family Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Ansely, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolina Ear, Nose and Throat Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Hendrick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kentucky Pediatric and Adult Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amy Agua, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Visions Clinical Research Boyton Beach</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bryan Harvey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Childrens Investigational Research Program</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Desert Clinical Research</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Osesky</last_name>
      <phone>480-898-1300</phone>
      <email>kosesky@crastudies.com</email>
    </contact>
    <investigator>
      <last_name>Gerald Shockey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Visions Clinical Research</name>
      <address>
        <city>Tuscon</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Pollock</last_name>
      <phone>520-546-4700</phone>
      <email>bpollock@visionstuscon.com</email>
    </contact>
    <investigator>
      <last_name>Steven Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Childrens Investigational Research Program</name>
      <address>
        <city>Bentonville</city>
        <state>Arkansas</state>
        <zip>72712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tonya Hogue</last_name>
      <phone>479-254-6722</phone>
      <email>thouge@chirpresearch.com</email>
    </contact>
    <investigator>
      <last_name>Bryan Harvey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Visions Clinical Research</name>
      <address>
        <city>Boyton Beach</city>
        <state>Florida</state>
        <zip>33472</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Coriaty</last_name>
      <phone>561-964-7880</phone>
      <email>lcoriaty@atlanticclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Amy Aqua, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kentucky Pediatric and Adult Research</name>
      <address>
        <city>Bardstown</city>
        <state>Kentucky</state>
        <zip>40004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marty Osbourn</last_name>
      <phone>502-349-1569</phone>
      <email>mpatterson.kpar@bardstowncable.net</email>
    </contact>
    <investigator>
      <last_name>James Hedrick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Ear, Nose and Throat Clinic</name>
      <address>
        <city>Orangeberg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone Ansley</last_name>
      <phone>803-563-5511</phone>
      <email>simoneharvey@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>John Ansley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foothill Family Clinic South</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mayra Vences</last_name>
      <phone>801-365-1032</phone>
      <email>mvences@jlewisresearch.com</email>
    </contact>
    <investigator>
      <last_name>Shane Christensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FirstMed East</name>
      <address>
        <city>Salt lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenny Bradley</last_name>
      <phone>801-733-4057</phone>
      <email>jbradley@jlewisresearch.com</email>
    </contact>
    <investigator>
      <last_name>Stephanie Plunkett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foothill Family Clinic</name>
      <address>
        <city>Salt lake City</city>
        <state>Utah</state>
        <zip>84109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara John</last_name>
      <phone>801-486-3021</phone>
      <email>kjohn@jlewisresearch.com</email>
    </contact>
    <investigator>
      <last_name>James Peterson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jordan River Family Medicine</name>
      <address>
        <city>South Jordan</city>
        <state>Utah</state>
        <zip>84095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Kimming</last_name>
      <phone>801-676-8109</phone>
      <email>ckimmig@jlewisresearch.com</email>
    </contact>
    <investigator>
      <last_name>Katie Julien, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 14, 2014</lastchanged_date>
  <firstreceived_date>January 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antipyrine</mesh_term>
    <mesh_term>Benzocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
